Side-by-side comparison of AI visibility scores, market position, and capabilities
Swedish BNPL leader listed on NYSE in 2024; Pay in 4 and financing across 500K+ merchants with AI-powered cost reduction and banking features after $45B valuation peak.
Klarna is a Swedish buy-now-pay-later (BNPL) and payments fintech providing consumers with flexible payment options — split payments (Pay in 4), pay later (Pay in 30), and financing — at checkout for online and in-store purchases across tens of thousands of retail partners. Founded in 2005 in Stockholm by Sebastian Siemiatkowski, Niklas Adalberth, and Victor Jacobsson, Klarna went public on the NYSE in July 2024 after years of private operation, raising approximately $1 billion and achieving a market capitalization of $6-8 billion — significantly below its 2021 peak private valuation of $45.6 billion.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.